The Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to apabetalone (Resverlogix Corp) in combination with standard of care therapy, including high-intensity statins, for the secondary prevention of major adverse cardiac events (MACE) in patients with type 2 diabetes mellitus and recent acute coronary syndrome.
Apabetalone is a first-in-class, small molecule, bromodomain and extraterminal domain (BET) inhibitor that selectively targets bromodomain 2 (BD2) at the transcription level. The investigational drug is believed to normalize dysregulated epigenetics of chronic diseases through selective BD2 inhibition. BET proteins are epigenetic readers that contribute to a variety of diseases by increasing production of dysregulated proteins.
The designation is supported by data from the phase 3 BETonMACE trial that evaluated the efficacy and safety of apabetalone in the prevention of MACE in high-risk type 2 diabetes patients with coronary artery disease (N=2425). Patients were randomized to receive either apabetalone 100mg twice daily or placebo, with standard of care therapy (high-intensity statin) for 120 weeks. The primary end point was the reduction in narrowly defined MACE, defined as a single composite end point of cardiovascular (CV) death, nonfatal myocardial infarction or stroke.
Results demonstrated that apabetalone did not meet the studys primary end point (hazard ratio [HR] 0.82 [95% CI, 0.65-1.04]; P =.11). However, apabetalone did achieve key secondary end points showing significant reductions in hospitalizations due to congestive heart failure vs placebo (HR 0.59 [95% CI, 0.38-0.94]), along with CV improvements in 2 prespecified subpopulations, including patients with chronic kidney disease. Moreover, patients with moderate to severe cognitive decline reported significant improvements in cognition when treated with apabetalone, as measured by Montreal Cognitive Assessment (MoCA).
This important designation the first for a major cardiovascular indication entails working closely with the FDA to facilitate a time-efficient drug development program including planned clinical trials and plans for expediting the manufacturing development strategy for apabetalone, said Donald McCaffrey, President and CEO.
The Company is also assessing the effects of apabetalone in patients with pulmonary arterial hypertension (early phase 1), end-stage renal disease treated with hemodialysis (phase 1/2), and Fabry disease (phase 1/2).
Follow @EndoAdvisor
For more information visit resverlogix.com.
This article originally appeared on MPR
Continue reading here:
Apabetalone Receives Breakthrough Therapy Designation for MACE Prevention - Endocrinology Advisor
- ST-Segment Elevation Myocardial Infarction - verywell.com - May 12th, 2018 [May 12th, 2018]
- Myocardial infarction (Heart Attack) - Health Facts - June 21st, 2018 [June 21st, 2018]
- Heart Attack and Acute Coronary Syndrome - Lab Tests Online - June 21st, 2018 [June 21st, 2018]
- Myocardial Infarction - ECGpedia - September 21st, 2018 [September 21st, 2018]
- Myocardial Infarction Clinical Presentation: History ... - September 25th, 2018 [September 25th, 2018]
- Myocardial infarction diagnosis - Wikipedia - September 25th, 2018 [September 25th, 2018]
- Myocardial Infarction Treatment & Management: Approach ... - October 9th, 2018 [October 9th, 2018]
- Myocardial infarction - Simple English Wikipedia, the free ... - October 18th, 2018 [October 18th, 2018]
- ST-Segment Elevation Myocardial Infarction - October 18th, 2018 [October 18th, 2018]
- ECG localization of myocardial infarction / ischemia and ... - October 18th, 2018 [October 18th, 2018]
- Heart Attack (Myocardial Infarction) Symptoms | Cleveland Clinic - November 15th, 2018 [November 15th, 2018]
- Myocardial Infarction (Heart Attack) Ischemia Pathophysiology, ECG, Nursing, Signs, Symptoms Part 1 - November 15th, 2018 [November 15th, 2018]
- Myocardial Infarction (MI) NCLEX Questions - November 30th, 2018 [November 30th, 2018]
- Myocardial Infarction NCLEX Review (Part 1) - December 3rd, 2018 [December 3rd, 2018]
- Acute Myocardial Infarction, Myocardial infection. Patient - December 4th, 2018 [December 4th, 2018]
- Heart Attack | Myocardial Infarction | MedlinePlus - December 16th, 2018 [December 16th, 2018]
- Heart Attack (Myocardial Infarction) - medicinenet.com - December 17th, 2018 [December 17th, 2018]
- Myocardial infarction (acute): Early rule out using high ... - December 20th, 2018 [December 20th, 2018]
- Conditions We Treat: Myocardial Infarction | Johns Hopkins ... - December 23rd, 2018 [December 23rd, 2018]
- Myocardial Infarction - Heart Home Page - December 25th, 2018 [December 25th, 2018]
- Myocardial infarction: signs symptoms and treatment ... - December 25th, 2018 [December 25th, 2018]
- ECGs in Acute Myocardial Infarction - ACLS Medical Training - December 25th, 2018 [December 25th, 2018]
- Myocardial Infarction - Eccles Health Sciences Library - December 27th, 2018 [December 27th, 2018]
- Myocardial Infarction: Practice Essentials, Background ... - December 27th, 2018 [December 27th, 2018]
- Myocardial infarction - Wikipedia - December 27th, 2018 [December 27th, 2018]
- Nursing Care Plan for Myocardial Infarction | NRSNG - December 29th, 2018 [December 29th, 2018]
- Cardiovascular disease - Myocardial infarction | Britannica.com - January 11th, 2019 [January 11th, 2019]
- Heart Attack (Myocardial Infarction) - Cedars-Sinai - January 11th, 2019 [January 11th, 2019]
- Top 5 MI ECG Patterns You Must Know | LearntheHeart.com - January 11th, 2019 [January 11th, 2019]
- Anterior Myocardial Infarction LITFL ECG Library Diagnosis - January 11th, 2019 [January 11th, 2019]
- Electrocardiography in myocardial infarction - Wikipedia - January 11th, 2019 [January 11th, 2019]
- Myocardial Infarction Therapeutics Market, Share, Growth ... - March 13th, 2019 [March 13th, 2019]
- Heart Attack (Myocardial Infarction) - Drugs.com - April 20th, 2019 [April 20th, 2019]
- STEMI (ST Elevation Myocardial Infarction): diagnosis ... - April 20th, 2019 [April 20th, 2019]
- Heart attack - Symptoms and causes - Mayo Clinic - April 20th, 2019 [April 20th, 2019]
- Cardiovascular models including myocardial infarction ... - April 27th, 2019 [April 27th, 2019]
- Myocardial infarction - Osmosis Video Library - May 1st, 2019 [May 1st, 2019]
- Myocardial Infarction - September 17th, 2019 [September 17th, 2019]
- Creatinine Rises After RAS Inhibitor Initiation Tied to Worse Outcomes - Renal and Urology News - September 19th, 2019 [September 19th, 2019]
- Ventricular Tachycardia Treatment Market Growth in Technological Innovation, Competitive Landscape Mapping the Trends and Outlook - NewsVarsity - September 19th, 2019 [September 19th, 2019]
- FDA Action Alert: Merck and Amarin - BioSpace - September 19th, 2019 [September 19th, 2019]
- Resverlogix Provides Update on BETonMACE Phase 3 Trial Toronto Stock Exchange:RVX - GlobeNewswire - September 19th, 2019 [September 19th, 2019]
- Marijuana Use Linked to Improved Acute-HF Hospital Survival - Medscape - September 19th, 2019 [September 19th, 2019]
- Population Health vs. Personalized Medicine: Lost in Translation? - American Council on Science and Health - September 19th, 2019 [September 19th, 2019]
- Bariatric Surgery Tied to Less MACE in Obesity, Diabetes - Medscape - September 19th, 2019 [September 19th, 2019]
- A Novel Algorithm for Improving the Diagnostic Accuracy of Prehospital ST-Elevation Myocardial Infarction - DocWire News - September 19th, 2019 [September 19th, 2019]
- Shock and Awe: ARNI for Acute HF May Be Safely Started in ICU - Medscape - September 19th, 2019 [September 19th, 2019]
- Global Myocardial Infarction Treatment Market Will Reach USD 1726.3 million by end of 2022 - Market News Store - September 19th, 2019 [September 19th, 2019]
- Frequency and Factors Related to Not Receiving Acute Reperfusion Therapy in Patients with ST Elevation Myocardial Infarction; A Single Specialty... - September 19th, 2019 [September 19th, 2019]
- Research Offers 10-Year Forecast on Myocardial Infarction Treatment Market - Rapid News Network - September 19th, 2019 [September 19th, 2019]
- University of Colorado study suggests Cannabis aids in surviving heart... - Communities Digital News - September 19th, 2019 [September 19th, 2019]
- SRH part of regional system award recognizing care for heart attacks - Index-Journal - September 19th, 2019 [September 19th, 2019]
- TherOx Announces Key SuperSaturated Oxygen Therapy Presentations at TCT 2019 - Yahoo Finance - September 19th, 2019 [September 19th, 2019]
- Incidence, Characteristics and Outcomes in Very Young Patients with ST Segment Elevation Myocardial Infarction - DocWire News - September 19th, 2019 [September 19th, 2019]
- Health Recovery After Acute MI Similar in Young Adults With and Without Diabetes - The Cardiology Advisor - September 19th, 2019 [September 19th, 2019]
- Rapid Diagnosis Protocol for Chest Pain Does Not Improve Outcomes - Diagnostic and Interventional Cardiology - September 19th, 2019 [September 19th, 2019]
- Diagnosis of Myocardial Infarction At Autopsy: AECVP Reappraisal in the Light of the Current Clinical Classification - DocWire News - September 19th, 2019 [September 19th, 2019]
- Global Myocardial Infarction Drug Market 2019 BioCardia, Inc., Biscayne Pharmaceuticals, Inc., Capricor Therapeutics, Inc., Cell - Market News Times - September 19th, 2019 [September 19th, 2019]
- Abiomed to Highlight Importance of Optimal PCI Treatment to Improve Outcomes for High-Risk Patients at TCT 2019 - Yahoo Finance - September 19th, 2019 [September 19th, 2019]
- ENTRUST-AF PCI Supports Safety of Dual Therapy With Edoxaban - Medscape - September 19th, 2019 [September 19th, 2019]
- Preoperative opioid use leads to perioperative consequences in foot and ankle surgery - Healio - September 19th, 2019 [September 19th, 2019]
- CV, General Safety of Long-Term PPI Use Examined - The Cardiology Advisor - September 19th, 2019 [September 19th, 2019]
- Effect of Delayed vs Immediate Interventions in Transient STEMI - The Cardiology Advisor - September 19th, 2019 [September 19th, 2019]
- Cardiorenal Disease Is the Most Common CVD Manifestation in Patients With T2D - Endocrinology Advisor - September 19th, 2019 [September 19th, 2019]
- DAPA-HF Published: 'Stunning Consistent Benefit With Dapagliflozin' - Medscape - September 19th, 2019 [September 19th, 2019]
- Geomagnetic Disturbances and Cardiovascular Mortality Risk - On Health - BMC Blogs Network - September 19th, 2019 [September 19th, 2019]
- Reconsidering the Safety of Intravenous Thrombolysis for Ischemic Stroke After Recent Myocardial Infarction - Neurology Advisor - September 19th, 2019 [September 19th, 2019]
- The Lowdown on Lipoprotein(a) - Medscape - October 9th, 2019 [October 9th, 2019]
- Protamine use found to significantly reduce reoperations for patients who undergo carotid endarterectomy - Vascular News - October 9th, 2019 [October 9th, 2019]
- Left Main Treated With PCI or CABG Have Similar Outcomes at Five Years - Diagnostic and Interventional Cardiology - October 9th, 2019 [October 9th, 2019]
- Sen. Sanders released from the hospital after heart attack - WXYZ - October 9th, 2019 [October 9th, 2019]
- E-Selectin Gene Haplotypes are Associated with the Risk of Myocardial Infarction - DocWire News - October 9th, 2019 [October 9th, 2019]
- BioVentrix Enrolls and Treats First Patient in REVIVE-HF European RCT for Ischemic Heart Failure Patients - P&T Community - October 9th, 2019 [October 9th, 2019]
- Quantitative Flow Ratio guided Residual Functional SYNTAX Score for Risk Assessment in Patients with ST-Segment Elevation Myocardial Infarction... - October 9th, 2019 [October 9th, 2019]
- Coronary Calcium Scan: The Role of Calcium Scoring in Preventing a First Myocardial Infarction - Consultant360 - October 9th, 2019 [October 9th, 2019]
- Sanders plans to 'change the nature' of campaign after heart attack - New York Post - October 9th, 2019 [October 9th, 2019]
- Early MI Linked to High Recurrent Events, Mortality - Medscape - October 9th, 2019 [October 9th, 2019]
- Sudden Cardiac Arrest and Ventricular Arrhythmias following first type I Myocardial Infarction in the Contemporary Era - DocWire News - October 9th, 2019 [October 9th, 2019]
- E-Cigarette Use and Myocardial Infarction - Physician's Weekly - October 9th, 2019 [October 9th, 2019]
- Sen. Bernie Sanders had heart attack; chest pains diagnosed as myocardial infarction - KIRO Seattle - October 9th, 2019 [October 9th, 2019]